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Abstract
Antimicrobial agents are being used in modern swine production worldwide, generating concern in 
regards to the development of antimicrobial resistance. Identifying efficient alternatives has therefore 
become a subject of interest. The aim of this study was to explore the impact of routinely used vaccination 
as an alternative to antimicrobial consumption in weaner pig herds. The hypothesis was that herds with 
increased use of vaccination would have a lower antimicrobial consumption. Data were obtained from the 
Danish VetStat database in which prescriptions of medication for livestock are recorded as well as the Danish 
Central Husbandry Register. All Danish one-site pig herds, active in year 2013, with >50 sows and >200 
weaners were selected for the study. Initially, data were analysed using a univariable model, and secondly 
a multivariable linear regression model was applied. The analyses included use of three different vaccines 
against Porcine Circovirus Type 2 (PCV2), Mycoplasma hyopneumoniae (M_HYO) and Lawsonia intracellularis 
(LAW), respectively, as well as annual production measured as number of weaners produced in a year. The 
outcome was the average antimicrobial consumption measured in animal daily does (ADD) per weaner pig. 
Out of the 1,513 herds selected for the study, 1,415 herds had antimicrobials prescribed for gastrointestinal 
disorders, and 836 for respiratory disorders. PCV2 vaccine was used in 880 herds, M_HYO vaccine in 787 and 
LAW vaccine was the least used, with 115 herds using it. The results suggested that antimicrobials to some 
extent were being used for other disease categories than those officially prescribed by the veterinarians. On 
average, herds using the different combinations of vaccines had higher use of antimicrobials than herds not 
using the vaccines – probably as a result of health problems in the herds existing prior to the initiation of 
vaccine use. Information about vaccination protocols, health status, biosecurity, and management practices 
was not available limiting the ability to assess causality.
Introduction
In the European Union (EU), antimicrobials (AM) are used extensively in veterinary medicine for therapeutic 
purposes, as metaphylactic treatment, or as prophylaxis to prevent disease (Aarestrup et al., 2008; Barton, 2014). 
This has led to concerns about the potential risk of the development of antimicrobial resistance (AR) in animals 
and the transfer of resistance factors from animals to humans, through zoonotic bacteria or consumption of 
animal products (Aarestrup et al., 2008; Allen et al., 2013; Seal et al., 2013). In Denmark, there has been political 
and public focus on this issue since the 1990s (Bager, 2000). As a result, a series of events emerged: phasing out 
of the use of AM as growth promoters; limited veterinary profit from sales of AM to 5-10% and development of 
guidelines for prudent use of AM. Moreover, in 2010 the Danish veterinary authorities adopted the Yellow Card 
initiative, a scheme that sets threshold limits to AM use in swine farms (Alban et al., 2013). That same year, an 
industry ban was implemented  to stop the use of cephalosporins (Alban et al., 2013; Jensen & Hayes, 2014). 
The measures listed above reflect the increasing political pressure that is forcing Danish pig producers to reduce 
the usage of AM in their farms. Therefore, efficient alternatives to routinely applied AM have become crucial. 
Vaccines are being considered as means to decrease the burden of animal diseases and also to reduce the need 
of AM for therapeutic purposes (Allen et al., 2013). However, the extent of using vaccination as an alternative to 
AM will depend on its cost, effectiveness and ease of use (Allen et al., 2013).
341340
Safepork 2015 Posters Epidemiology and control of hazards in pork production chain – SAFEPORK
One health approach under a concept of farm to fork
To explore the impact of further use of vaccination as an alternative to AM, the present study was carried 
out using data from Danish pig herds covering the year 2013. The aim was to investigate overall associations 
between vaccination against PCV2, M_HYO and LAW and antimicrobial consumption (AC). The hypothesis 
was that herds with increased use of vaccination would have a lower AC.  
Material and Methods
The data used in this study were obtained from VetStat and the Danish Central Husbandry Register. All 
Danish one-site pig herds, active in the year 2013, with >50 sows and >200 weaners were selected for the 
study (N=1,513 herds). In VetStat, the AC is divided into three age groups: sows with piglets, weaners (7 – 30 
kg), and finisher pigs. Moreover, the indication the AM were prescribed for is recorded. Only the AC for the 
weaners was taken into account in the present analysis. In Denmark there are 8 weeks between batches 
in the nursery. This implies that 52/8 = 6.5 weaners can be produced per year per pen place. Therefore, a 
conversion factor of 6.5 was used to go from the number of pen places to the number of weaners produced 
per pen place per year.
For each of the 1,513 herds, a variable was created to reflect the AC per weaner produced per year (2013). 
This variable was calculated using the total administered animal daily does (ADD) in weaners in 2013, for 
each herd, divided by the number of pen places for weaners, multiplied by 6.5. Also, to be able to assess 
if the production level had an influence on the AC in weaners, the annual production (AP) of weaners was 
estimated for each herd by using the number of pen places for weaners multiplied by 6.5. 
For this study, the AC in weaners is presented by treatment indication. This allows for investigation of 
biologically meaningful correlations of the AC in weaners and the different vaccinations applied. Three 
different outcomes were analysed: (1) total AC (TAC) covering all diagnostic groups as applied in VetStat: a) 
reproduction, urogenital system; b) udder; c) gastrointestinal system; d) respiratory system; e) joints, limbs, 
hooves, central nervous system, skin and f) metabolism, digestion, circulation); (2) AC with gastrointestinal 
indication only (ACGI) and (3) AC with respiratory indication only (ACRI). All analyses were carried out in 
R (version 3.1.2). Univariable analyses were performed for TAC, ACGI, and ACRI, respectively. A t-test was 
conducted for each of the three types of vaccination comparing herds using the vaccine versus herds which 
did not use the vaccine. Subsequently, multivariable analyses were performed for 1) TAC, 2) ACGI, and 3) ACRI 
as three individual outcomes. The explanatory variables were AP and vaccine use. The latter variable had 
eight levels which reflected all combinations between the three different vaccines. It was tested whether AP 
was significantly associated with the response and whether it acted as a confounder by being associated with 
the vaccine use. A P-value < 0.05 was used as threshold for statistical significance.
Results
Out of the 1,513 herds selected for the study, all of them had AM prescribed for the total of diagnostic 
groups, 1,415 had AM prescribed for gastrointestinal disorders, and 836 for respiratory disorders. Concerning 
the different vaccines, 880 herds used the PCV2 vaccine, whereas M_HYO vaccination was used in 787 herds, 
and LAW vaccination was the least used vaccine, with just 115 herds using it. In the following the mean ADD 
per weaner per year will be reported as ADD.
Univariable analysis
Concerning TAC: herds using PCV2 vaccination (TAC=103.9 ADD, p<0.0001) or M_HYO vaccination 
(TAC=106.4 ADD, p<0.0001) had a higher mean of AC per weaner than herds not using each of these vaccines 
(TAC= 86.3 ADD and TAC=85.9 ADD, respectively) whereas herds using LAW vaccination had a lower mean of 
AC (TAC=85.6 ADD, p=0.04) than the ones not using it (TAC= 97.4 ADD). The AP explained 0.5% of the variance 
in TAC (R2=0.005, F=8.6, p=0.004). 
Regarding ACGI: herds using PCV2 vaccine (ACGI=72.2 ADD, p=0.01) had a notably higher mean of AC than 
those not using it (ACGI=64.6 ADD). The AP had no influence on the ACGI (p=0.5). 
Regarding ACRI: herds using M_HYO vaccination (ACRI=48.2 ADD, p=0.0006) had a substantially higher 
mean ACRI than herds not using the vaccine (ACRI=34.0 ADD). On the contrary, herds using LAW vaccination 
(ACRI=22.2 ADD, p<0.0001) had only half mean ACRI compared to those not using the vaccine (AC=44.5 ADD). 
AP had no influence on ACRI (p=0.6).
Multivariable analysis
Regarding TAC, the results revealed that a model containing AP and different combinations of vaccines 
explained a total of 3% of the variance in the AC (R2=0.03, F=7.2, p<0.001). The output of the model also 
showed that, when the AP increases by 1000 weaners, the ADD per weaner per year (TAC), increases by 4 
ADD. The use of M_HYO vaccination alone (N=221) or together with PCV2 vaccination (N=507) was associated 
with a statistical higher TAC than group 0 representing use of none of the three vaccines (N=380): TAC was 
19.9 and 31.8 ADD higher per weaner compared with group 0, respectively. The use of only PCV2 vaccination 
(N=290) was associated with 15.3 ADD per weaner more when compared to group 0. The rest of the groups, 
reflecting the remaining vaccine combinations, were not associated with statistically different levels of TAC 
(p>0.05). 
Regarding ACGI, PCV2 vaccination was the only significant variable and explained 0.4% of the variance in 
the ACRI (R2=0.004, F=6.1, p=0.01). Herds using PCV2 vaccination (N=830) were associated with a statistically 
higher (7.6 ADD) ACGI, than herds not using this vaccination (N=585). 
In relation to the ACRI, the results indicated that the variable representing different combinations of 
vaccines explained 2% of the variance in the ACRI (R2= 0.02, F=3.5, p=0.001). This final model suggested that 
use of M_HYO vaccination alone (N=134) or in combination with PCV2 vaccination (N=349) was associated 
with a higher ACRI, compared to group 0. M_HYO vaccine alone was associated with 24.7 ADD more per 
weaner compared to group 0; and M_HYO+PCV2 vaccination with 17.3 ADD more (ACRI) compared to group 
0. The changes in ACRI associated with the remaining vaccine combinations were not statistically significant 
(p>0.05).
Discussion
LAW vaccination is used to prevent proliferative enteropathy (Stege et al., 2000). Thus, it would have been 
expected that ACGI would have been reduced in herds using the vaccine instead of the ACRI, as shown in 
our results. This could suggest that – too some extent – AM are being used for other disease categories than 
those officially prescribed by the veterinarians. Certain AM, such as some doxycyclines, are not registered 
for treating infections with gastrointestinal indication in Denmark, although they are known to be effective 
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in everyday practice (contact to Danish pig veterinarians). These findings are in agreement with previous 
studies and suggest that using this vaccine could reduce the amount of AMs used in pig herds – see e.g. Bak 
and Rathkje (2009) and Thaker and Bilkei (2006).
However, the results of the multivariable analyses revealed that when taking into account all three vaccines 
simultaneously, the differences in AC between the groups that used LAW vaccination and those that did not 
use it, were no longer statistically significant. This probably because only 62 herds (7.4%) used this vaccine – 
hence the effect was “diluted” in the large analysis. 
Herds using M_HYO vaccination had a higher ACRI than herds not using it. It is likely that these herds had 
previously detected M_HYO and, subsequently, had had a higher ACRI because of need to control M_HYO 
infection. Thacker and Minion (2012) point to the predisposition of M_HYO–infected animals to secondary 
invaders, especially other pulmonary pathogens. Another explanation is that these herds could have been 
using AM with the aim of preventing respiratory disorders and, after detecting M_HYO, started the vaccina-
tion as a complementary tool. This approach makes sense, since  pigs treated with AM such as tetracyclines 
and macrolides have less clinical signs and a lower number of secondary infections (Vicca et al., 2004;Cip-
rián et al., 2012). Moreover, vaccination is associated with reduced clinical signs, diminished lung lesions 
and fewer treatment costs (Maes et al., 1999).
Herds using PCV2 vaccination had a higher ACGI than those not using it. PCV2 is associated with enteritis, 
which may explain the higher ACGI for vaccination and, at the same time higher ACGI weaners. Above all, 
the weaners as an age group are associated with gastrointestinal inflammation, increased permeability 
of the gut (Moeser and Blikslager, 2007) and high occurrence of diarrhoea that may lead to high AM use 
(Oostindjer et al., 2014). These herds could also have initiated routine to PCV2 vaccination with the aim of 
preventing various other clinical syndromes which PCV2 can be linked to (Tomás et al., 2008). Moreover 
this vaccination has been associated with decreased mortality rate and increased average daily weight gain 
(Kristensen et al., 2011).
Herds that used both M_HYO and PCV2 vaccines were associated with a higher ACRI when compared to 
those not using any of the three vaccines. However, when M_HYO and PCV2 were used together, ACRI were 
lower than the ones just using M_HYO. This suggests that the use of both vaccines might provide a better 
immune protection to the animals than the use of M_HYO on its own and therefore, reducing the need for 
AM. In fact, interaction between both of these agents has been described previously (Harms et al., 2002; 
Kim et al., 2003). Herds that used both M_HYO and PCV2 vaccines were associated with increased TAC com-
pared to the ones not using any of the three vaccines. In this situation, is possible that presence of M_HYO 
amplified the persistence of PCV2, that is in agreement with previous studies (Opriessnig et al., 2004). Thus, 
being the ones with a higher TAC. Another possibility is that these herds have been using AM routinely with 
the aim of preventing/treating early health problems and, after detection, started vaccination against both 
of these agents. Results also showed a lower TAC in herds which used PCV2 vaccination alone compared 
to herds that used both PCV2 and M_HYO vaccines. These findings are in agreement with an experimental 
study undertaken by Seo et.al (2014), which aimed at determining the effects of both vaccines in disease 
severity. On the other hand, PCV2 is linked with several disease syndromes. Thus, protection by vaccination 
may be justified to use less AM for various indications. 
The F-statistics for the final models suggest a strong association between the AC and the use of vaccines. 
However, the adjusted squared correlation coefficient (R2) for all three final models was low, which means 
that other unknown factors are important to describe the variation in AC. Some of the possible factors are: 
(1) vaccination protocols, (2) time of vaccination, (3) use of other vaccines, (4) herd health status, (5) internal 
and external biosecurity, (6) management practices, (7) turnover of animals in each herd and (8) requirement 
from buyers of weaners. At the time of this study, this information was not available limiting the ability to 
assess causality.
 
Conclusion
On average, herds using the different combinations of vaccines had higher use of antimicrobials than 
herds not using the vaccines – probably as a result of health problems in the herds existing prior to the use 
of vaccination. 
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